Posted

Bridge to Life Ltd. Announces Early Results from its Pivotal Bridge to HOPE Liver Clinical Trial

The Bridge to HOPE trial is being conducted under U.S. Food and Drug Administration (FDA) approved investigational device exemption (IDE) to evaluate the clinical safety and efficacy of static [...]

Posted

Bridge to Life Ltd. Announces First Enrollment and Orthotopic Liver Transplantation in its Pivotal Bridge to HOPE Liver Clinical Trial

Bridge to Life Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, announced first enrollment and orthotopic liver transplantation in its U.S. [...]

Posted

Bridge to Life Ltd. Receives Investigational Device Exemption Approval from the FDA

The primary endpoint for the trial is the rate of early allograft dysfunction between treatment groups; additional key endpoints include rates of ischemic cholangiopathy and patient and graft [...]

Posted

Bridge to Life Announces First Close of $56 Million Growth Financing Led by Perceptive Advisors

Bridge to Life, Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, announced the first closing of a growth financing, totaling $56 million, led by [...]

Posted

Bridge to Life and Tevosol Merge to Commercialize Portable Normothermic Machine Preservation Technology Platform for Organ Transplantation

Bridge to Life, Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, and Tevosol, Inc., a clinical stage medical device startup, today announced their [...]